CA
NZ
UK
AU
IND
US
Director Nathaniel Simmons of Consensus Cloud Solutions, Inc. filed a Form 144 notice of proposed sale of 8,003 shares of common stock, with an approximate sale date of November 9, 2026, executed through Morgan Stanley Smith Barney LLC.
Director Joseph P. Slattery filed a Form 144 notice with the U.S. Securities and Exchange Commission on November 9, 2026, disclosing a proposed sale of 5,200 shares of Replimune Group, Inc. common stock through Morgan Stanley Smith Barney LLC.
Arthur J. Gallagher & Co. officer Susan E. Pietrucha filed a Form 144 notice of proposed sale of 15,020 shares of common stock on November 9, 2026, following a stock option exercise from the issuer on the same date.
Director Anthony M. Eisen filed a Form 144 notice with the SEC on November 9, 2026, disclosing a proposed sale of 100,000 shares of Block, Inc. common stock on NYSE, with an aggregate market value of $8,900,000.00.
Joseph Konowiecki, Chairman and EVP of Corporate Affairs at Alignment Healthcare, Inc., filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 5,500 shares of common stock with an approximate sale date of November 10, 2026.
Christopher Kubasik, an officer of L3Harris Technologies, Inc., filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 15,000 shares of L3Harris common stock through Goldman Sachs & Co. LLC on the New York Stock Exchange.
Castle Biosciences, Inc. Chief Commercial Officer Tobin Juvenal filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 13,154 shares of common stock through Goldman Sachs & Co. LLC with an aggregate market value of $452,234.52.
The Jonathan R. Scott Trust dated 11/13/2004, a former director-affiliated trust of First Interstate BancSystem, Inc., filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 10,000 shares of common stock through Goldman Sachs & Co. LLC.
Kevin Perhamus, an officer of Arxis, Inc., filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 25,000 common shares through Goldman Sachs & Co. LLC under a Rule 10b5-1 trading plan.
Director Fabio Rosati filed a Form 144 notice with the SEC on November 9, 2026, disclosing a proposed sale of 5,400 Class A Common Shares of Xometry, Inc. through Goldman Sachs & Co. LLC.
Please wait processing your request...